Nantahala Capital Management, LLC Harpoon Therapeutics, Inc. Transaction History

Nantahala Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.54 - $8.08 $1.68 Million - $3.84 Million	-475,467 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.69 - $7.83 $324,238 - $446,184	56,984 Added 13.62%	475,467 $3.59 Million
Q3 2021 Nov 15, 2021	SELL	$7.88 - $14.0 $195,140 - $346,696	-24,764 Reduced 5.59%	418,483 $3.31 Million
Q2 2021 Aug 16, 2021	SELL	$13.81 - $23.25 $132,106 - $222,409	-9,566 Reduced 2.11%	443,247 $6.15 Million
Q1 2021 May 14, 2021	BUY	$17.65 - $24.16 $7.99 Million - $10.9 Million	452,813 New	452,813 $9.47 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.